You are here: Industry Insights > Alzheimer's Disease

News List

UK MRC researchers reveal structures of tau filaments from Alzheimer's disease pharmaceutical-technology
July 10, 2017
Scientists at Britain’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) have uncovered the atomic structure of tau protein filaments, which lead to Alzheimer's disease.
Lundbeck secures rights to IBC's research for Alzheimer's treatment pharmaceutical-technology
June 08, 2017
Danish pharmaceutical company Lundbeck has signed an agreement to secure the rights of biotech firm ImmunoBrain Checkpoint’s (IBC) breakthrough research in Alzheimer's disease treatment.
Gene Test Needed Before Using Alzheimer's Drug 'Off-Label' drugs.com
March 08, 2017
A drug used to treat Alzheimer's disease should not be prescribed to people with milder mental impairment without first giving them a genetic test, a new study urges.
Genentech to launch second PhIII trial of Alzheimer’s drug pharmatimes
March 02, 2017
Roche's Genentech is launching a second Phase III trial of anti-Abeta antibody crenezumab in patients with ...
Lundbeck's experimental Alzheimer's disease drug idalopirdine fails two further late-stage studies firstwordpharma
February 09, 2017
Lundbeck disclosed Wednesday that two Phase III studies of the experimental drug idalopirdine in patients with Alzheimer's disease failed to demonstrate efficacy of the 5-HT6 antagonist.
AstraZeneca and Lilly to develop second potentially disease-modifying treatment for Alzheimer's dise worldpharmanews
January 16, 2017
AstraZeneca and Eli Lilly and Company have announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42), which is currently in Phase I trials as a potential disease-modifying treatment for Alzheimer's disease (A

Previous page 1 2 3 4 Next page